[go: up one dir, main page]

WO2019241832A1 - Dispositif de dosage avec distributeur et cartouche - Google Patents

Dispositif de dosage avec distributeur et cartouche Download PDF

Info

Publication number
WO2019241832A1
WO2019241832A1 PCT/AU2019/050613 AU2019050613W WO2019241832A1 WO 2019241832 A1 WO2019241832 A1 WO 2019241832A1 AU 2019050613 W AU2019050613 W AU 2019050613W WO 2019241832 A1 WO2019241832 A1 WO 2019241832A1
Authority
WO
WIPO (PCT)
Prior art keywords
dispenser
delivery device
reservoir
pump
housing assembly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/AU2019/050613
Other languages
English (en)
Inventor
Antony CONDINA
Jeen Joseph Chacko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gd Pharma Pty Ltd
Original Assignee
Gd Pharma Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2018902244A external-priority patent/AU2018902244A0/en
Application filed by Gd Pharma Pty Ltd filed Critical Gd Pharma Pty Ltd
Publication of WO2019241832A1 publication Critical patent/WO2019241832A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/08—Inhaling devices inserted into the nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/006—Sprayers or atomisers specially adapted for therapeutic purposes operated by applying mechanical pressure to the liquid to be sprayed or atomised
    • A61M11/007—Syringe-type or piston-type sprayers or atomisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
    • B05B11/0005—Components or details
    • B05B11/0037—Containers
    • B05B11/0054—Cartridges, i.e. containers specially designed for easy attachment to or easy removal from the rest of the sprayer
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
    • B05B11/01—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use characterised by the means producing the flow
    • B05B11/02—Membranes or pistons acting on the contents inside the container, e.g. follower pistons
    • B05B11/025—Membranes or pistons acting on the contents inside the container, e.g. follower pistons with stepwise advancement of the piston, e.g. for spraying a predetermined quantity of content
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0021—Mouthpieces therefor
    • A61M15/0025—Mouthpieces therefor with caps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/27—General characteristics of the apparatus preventing use
    • A61M2205/273—General characteristics of the apparatus preventing use preventing reuse, e.g. of disposables
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/27—General characteristics of the apparatus preventing use
    • A61M2205/276—General characteristics of the apparatus preventing use preventing unwanted use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/06—Head
    • A61M2210/0612—Eyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/06—Head
    • A61M2210/0618—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/06—Head
    • A61M2210/0625—Mouth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/06—Head
    • A61M2210/0662—Ears
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
    • B05B11/01—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use characterised by the means producing the flow
    • B05B11/02—Membranes or pistons acting on the contents inside the container, e.g. follower pistons
    • B05B11/028—Pistons separating the content remaining in the container from the atmospheric air to compensate underpressure inside the container
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
    • B05B11/01—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use characterised by the means producing the flow
    • B05B11/10—Pump arrangements for transferring the contents from the container to a pump chamber by a sucking effect and forcing the contents out through the dispensing nozzle
    • B05B11/1042—Components or details
    • B05B11/1059—Means for locking a pump or its actuation means in a fixed position
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D2401/00—Tamper-indicating means
    • B65D2401/15—Tearable part of the closure
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D41/00—Caps, e.g. crown caps or crown seals, i.e. members having parts arranged for engagement with the external periphery of a neck or wall defining a pouring opening or discharge aperture; Protective cap-like covers for closure members, e.g. decorative covers of metal foil or paper
    • B65D41/32—Caps or cap-like covers with lines of weakness, tearing-strips, tags, or like opening or removal devices, e.g. to facilitate formation of pouring openings
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D55/00—Accessories for container closures not otherwise provided for
    • B65D55/02—Locking devices; Means for discouraging or indicating unauthorised opening or removal of closure

Definitions

  • the present invention relates generally to a device for administering a dose of liquid medicament, therapeutic or other fluid.
  • the dosage device is of the type with a dispenser used with cartridges which may be replaceable, or alternatively the entire device is a ‘single use’ device that is discarded once the cartridge is empty.
  • the dosage device is a spray device that may be used for delivering opioid medicaments nasally or orally to a patient.
  • Pain relief drugs such as fentanyl can be readily administered nasally. Consequently, in Australia paramedics and ambulance officers have been administering nasal fentanyl to patients requiring prompt pain relief since about 1990.
  • Nasal delivery is achieved by drawing the required dosage using a syringe from an ampoule or vial, and then squirting the dosage from the syringe by depression of the plunger directly into the nasal cavity of the patient.
  • fentanyl is typically available in 100mcg/2ml ampoules. As such, this product is too dilute to deliver the required dosage of up to 200mcg for adults and up to 50mcg for children. This is because with such a commercial product it would be necessary to instil 4ml nasally for adults and 1 ml for children. Given that the nasal cavity can only hold up to 0.2ml volume before run off occurs down the nose or at the back of the throat, delivery of volumes greater than 0.2ml is ineffective.
  • fentanyl has been supplied in a 600mcg/2ml concentrated form in a vial. Again however, a 200mcg dose for adults would require 0.33ml to be instilled to each nostril of the patient resulting in run off and thus incorrect patient dosage. Further, once the 200mcg dosage has been given to the patient from the 2ml vial, more than 1 ml of product remains in the vial which may be diverted for illicit use. [0004] Another problem with current arrangements for delivering drugs such as fentanyl nasally at an accident scene is that the orientation of the patient may be such that delivery into the nostril is ineffective.
  • fentanyl may simply run out of the patient’s nostril before transmucosal uptake or the patient’s orientation may not allow administration using a plunger controlled type device.
  • Fentanyl nasal spray is available for the management of breakthrough pain in adult cancer patients who are tolerant to opioid therapy for their underlying persistent cancer pain.
  • the use of such sprays is closely controlled and the devices are intended for use by specific patients with known medical history.
  • Such devices are not suitable for use by paramedics or ambulance officers because of the volume remaining in the glass bottle containing the fentanyl after a single patient use.
  • the pump of such sprays is permanently attached to the glass bottle containing the opioid and thus it is not possible to select a pump size as needed for a particular patient.
  • US patent 7,296,566 teaches a nasal spray device including a drug container, in the form of a syringe, and a separable spray nozzle.
  • the nozzle includes an internal valve which only allows pressurized liquid to flow through a conduit in the nozzle so that a mist or spray of medicament is released when the plunger is pressed by the user.
  • US 2002/0174865 teaches a nasal spray system including a standard syringe, a disposable pre-filled nasal spray tip, and a disposable snap cap for protection of the tip.
  • the snap cap is removed and the syringe mated to the nasal spray tip.
  • the syringe plunger is pushed into the syringe forcing atomized fluid to be dispensed into the nasal passage.
  • EP 2011467 describes a fluid container and an airless fluid dispensing system that does not rely on a plunger type delivery system.
  • the fluid container holds a gel liquid which is sucked out of the container and dispensed via the spout when a pump is actuated.
  • the device must be primed to remove air from within the container space and from within the pump itself. This requires the user to depress the pump a number of times so as to evacuate all air from within the pump and the container. It is only after that action occurs and thus the device is primed, that fluid can be dispensed.
  • a delivery device that can reliably deliver the required patient dosage of a medicament.
  • a delivery device is also configured to provide evidence of any prior tampering with the medicament.
  • a delivery device is also preferably configured or useable such that only a minimal amount of any medicament is retained in the device after normal use and/or which device can be locked to prevent later use or extraction of any remaining medicament.
  • the present invention seeks in one aspect to provide an improved a delivery device.
  • the invention seeks to provide an improved tamper evident dosage cartridge for housing a medicament vial.
  • the various aspects of the invention may address one or more of the deficiencies of the prior art mentioned above.
  • the present invention provides a delivery device for dispensing a dose of liquid medicament, therapeutic or other fluid
  • the delivery device comprising: a dispenser for manual actuation by a user to dispense the dose, the dispenser having a flow path extending from an inlet to an outlet via a pump such that manual actuation of the pump when primed with the liquid, dispenses a predetermined dosage through the outlet; and a housing assembly with a reservoir for a quantity of the liquid and a coupling to detachably engage the dispenser and form a fluid connection between the reservoir and the outlet; wherein the housing assembly has a priming element configured to act on the reservoir as the coupling engages the dispenser to prime the pump with liquid expelled from the reservoir.
  • the initial actuations of the delivery device will reliably dispense a known dosage of the medicament (or other liquid). This avoids inadequate dosage to patients who may not receive the necessary level of pain relief which can adversely affect their medical care. Furthermore, as discussed above, incomplete dosage can mislead medical personnel if the patient’s response to a perceived pain relief dosage is understated.
  • the reservoir is tubular and has a plunger for engaging the priming element such that the priming element displaces the plunger to reduce the reservoir volume by an amount required to prime the pump.
  • the priming element has a priming pin configured for a predetermined length of axial travel along the reservoir, such that the plunger also travels the predetermined length when the coupling engages the dispenser.
  • the coupling on the housing assembly has engagement formations for engagement with complementary formations on the dispenser via relative movement of the engagement formations in a direction parallel to the longitudinal axis of the reservoir.
  • the engagement formations and the complementary formations are configured to inter-engage via relative movement parallel to the longitudinal axis of the reservoir followed by relative rotation of the engagement formations and the complementary formations to engage the dispenser and the housing assembly.
  • the dispenser and the housing assembly are configured to resist disengagement from each other.
  • the dispenser and the housing assembly inter-engage for selective configuration into a locked position preventing user actuation of the pump and an unlocked position allowing user actuation of the group.
  • the pump is manually actuable between a primed condition in which the pump holds a dose of the liquid and a discharged condition for discharging the dose to the outlet, the pump being resiliently biased to the primed condition such that the pump primes with liquid from the reservoir after manually actuating the pump to discharge the liquid.
  • the priming element has a locating collar connected to the priming pin by one or more frangible bridges, such that the locating collar positions the priming pin until an axial insertion force on the housing assembly fractures the frangible bridges, allowing the priming pin to displace the plunger by the predetermined length of travel needed to prime the pump.
  • the reservoir has a syringe barrel within a cartridge casing, the syringe barrel holding the liquid medicament and the cartridge casing having the engagement formations for inter-engagement with the complementary formations on the dispenser, the syringe barrel having an outlet connector for fluid connection with the inlet of the dispenser, such that inter-engagement of the housing assembly and the dispenser axially displaces the reservoir relative to the cartridge housing which in turn primes the pump by forcing the plunger onto the priming element resulting in the displacement of the plunger towards the outlet connector of the syringe barrel.
  • the cartridge casing has an interior surface shaped to fit with a complementary external surface on the syringe barrel to hold the outlet connector at a fixed position relative to the cartridge casing.
  • the external surface of the syringe barrel has longitudinal ribs for sliding inter-engagement with channels in the cartridge casing interior.
  • the housing assembly has an end cap at a distal end portion of the reservoir opposite the engagement formations, the end cap holding the priming element for engagement with the plunger in the syringe barrel, and the end cap having a peripheral skirt attached to the cartridge housing such that attempts to remove the end cap result in tamper evident damage to the end cap and/or the cartridge housing.
  • the cartridge casing has snap lock formations to retain the end cap at the distal end portion, the snap lock formations allowing assembly of the endcap onto the distal end portion but not subsequent removal of the endcap without damage to the cartridge casing and/or the end cap.
  • the housing assembly has a removable cap at a proximal end of the reservoir for removal prior to engaging the dispenser, the removable cap having features preventing contact between the engagement formations and the complementary formations, and is not capable of re-attachment to the proximal end of the reservoir once removed.
  • the removable cap connects to the proximal end via an integrally formed line of weakness and the features preventing contact are diametrically opposed finger tabs, such that a user applied torque to the finger tabs sheers the removable cap along the line of weakness.
  • the cartridge casing has at least one window for viewing the syringe barrel and the syringe barrel is transparent to provide visual indication of the liquid medicament level in the syringe barrel.
  • the housing assembly has a first metal security disc in the end cap and a second metal security disc in the removable cap.
  • the outlet connector of the syringe barrel is a male luer connector extending from the proximal end
  • the inlet of the dispenser is a female luer connector positioned relative to the complementary formations of the bayonet coupling such that the male and female luer connectors form the fluid connection upon inter-engagement of the housing assembly and the dispenser.
  • the dispenser has a tapered nozzle defining the outlet, and a flange with textured finger grip surfaces on opposing sides for manual actuation of the pump.
  • the dispenser has a spray generating insert attached to the pump outlet such that the liquid is dispensed from the nozzle as a spray.
  • the present invention provides a housing assembly for use in a liquid medicament delivery device with a manually actuated dispenser, the housing assembly comprising: a reservoir for a quantity of the medicament; a coupling for detachable engagement with the dispenser; and a priming element configured to act on the reservoir as the coupling engages the dispenser to prime the dispenser with medicament expelled from the reservoir.
  • the priming element displaces volume within the reservoir is displaced during inter-engagement of the housing assembly and the dispenser such that displacement of the priming element reduces the reservoir volume by an amount required to prime the dispenser.
  • the invention provides a manually actuated dispenser for use in a medicament delivery device, the dispenser comprising: a flow path extending from an inlet to an outlet via a pump and complementary formations for inter-engagement with a coupling formed on a detachable housing assembly in accordance with second aspect described above, such that inter-engagement between the dispenser and the housing assembly primes the pump with the medicament.
  • Figure 1 shows a dispensing device according to the present invention
  • Figures 2 and 3 show the plan and side elevations respectively for use in the dispensing device shown in Figure 1 ;
  • Figure 4 is a cross-sectional view of the housing assembly shown in Figures 3, taken along line A-A;
  • Figure 5 is an axially exploded perspective of the housing assembly shown in Figures 2 to 4;
  • Figure 6 is a side elevation of the dispenser of the delivery device shown in Figure 1 ;
  • Figure 7 is a cross-sectional view of the dispenser shown in Figure 6, taken along line A-A; and
  • Figure 8 is an axially exploded perspective of the dispenser shown in Figures 6 and 7.
  • the delivery device 2 is shown with the manually actuated dispenser 4 inter-engaged with the housing assembly 6 via the coupling 16.
  • the housing assembly 6 holds a quantity of liquid medicament, therapeutic or other liquid that is drawn into the dispenser 4 by manual actuation of the pump (discussed below) to dispense a spray from the outlet 12 at the tip of the nozzle 14.
  • the delivery device is dimensioned such that the middle finger and the index finger press on the opposing finger grip flanges 8, while the endcap 10 is supported in the palm of the hand. Pressing the dispenser 4 down onto the housing assembly 6 actuates a pump 60 to force the liquid through a spray insert 58 and out the outlet 12.
  • the pump is resiliently biased to return to the primed condition which simultaneously draws the next dose of liquid from the housing assembly 6 and into the pump chamber 68.
  • the outer peripheral skirt 64 of the dispenser 4 is generally elliptical in cross section.
  • the housing assembly 6 is positioned so that the engagement tabs 22 align with the major axis of the elliptical skirt 64 of the dispenser 4.
  • the housing assembly 6 can be inserted into the skirt 64 (once the removable cap 18 (discussed below) has been removed) as the engagement tabs 22 fit within the long axis of the elliptical cross section.
  • the (now exposed) male luer connector 32 engages the female luer connector 62 to form a fluid tight connection.
  • the housing assembly 6 is pushed up into the elliptical skirt 64 of the dispenser 4 which in turn pushes the female luer connector 62 towards the pump 60, while also pushing the syringe barrel 30 downwards within the cartridge casing 26.
  • the force applied to the syringe barrel 30 presses on the locating collar 48 of the priming pin 40 to break the frangible bridges 76. This allows the syringe barrel 30 to push the locating collar 48 to the base 46 and the end cap 10, while the priming pin 40 displaces the plunger 24 towards the male luer connector 32. Displacement of the plunger 24 expels liquid medicament from the syringe barrel 30 into the flow path 66 of the dispenser 4.
  • the dispenser 4 and the housing assembly 6 are rotated relative to each other so that the engagement tabs 22 are forced into an apertures 80, 82 in the peripheral skirt 64.
  • Skilled workers in field will understand that the structure and polymer of the peripheral skirt 64 and/or the engagement tabs 22 can be selected such that some elastic deformation (with undue force) will allow the tabs 22 to slide across the interior of the skirt 64 until they reach the apertures 80, 82. Here the elastic deformation is released and the tabs 22 protrude into the apertures to retain the dispenser 4 on the housing assembly 6.
  • the apertures are asymmetrical with a tall section corresponding to an unlocked position 80 for the dispenser 4, and a short section corresponding to a locked position 82 for the dispenser.
  • the female luer connector 62 is pressed up into the discharge position as the syringe barrel 30 is forced down into the cartridge housing 26 (as discussed above).
  • the tabs 22 are relatively high in the peripheral skirt 64 and both reach the top of the tall section 80.
  • the compression applied to the dispenser is released and the return spring (or similar resilient bias) in the pump 60 pushes the dispenser away from the housing assembly.
  • the dispenser may be rotated a few degrees so that the tabs 22 move across into the short section 82 where their movement is more restricted, thereby locking the dispenser from being manually actuated. This is a useful precaution against unintentional actuation of the dispenser 4, or a child safety lock particularly if a degree of resistance in moving from the locked position 82 to the unlocked position 80 is incorporated.
  • FIGS 2 to 5 illustrate the features of the housing assembly 6 in detail.
  • the housing assembly 6 is provided in the form of a cartridge intended for a single use with the dispenser 4. Once the housing assembly 6 is empty, the dispenser 4 is rotated to a locked position and the complete device 2 is carefully disposed as there may be some residual medicament (e.g. opioids) in the syringe. However, the invention equally applies to a situation in which the empty cartridge is simply replaced and the dispenser is re-used.
  • the top or proximal end of the housing assembly has a removable cap 18 that is integrally moulded and connected with the cartridge casing 26 via a line of weakness 34 (best seen in Figure 4). On diametrically opposed sides of the removable cap 18 are protruding finger tabs 20.
  • the user twists the finger tabs 20 to apply a torque to the line of weakness 34 which sheers away from the cartridge casing 26. This provides a tamper evident feature as the removable cap 18 cannot be replaced once the line of weakness 34 has been fractured. Furthermore, the finger tabs 20 not only provide the protrusions to manually apply torque but also act as guarding formations to prevent inter-engagement of the dispenser 4, and the housing assembly 6 until the cap 18 is removed.
  • the upper security disc 54 and luer cover 50 are also removed.
  • the upper security disc 54 is typically metal or another hardened material to prevent tampering with the medicament via insertion of a needle.
  • the luer cover 50 seals the male luer connector 32 at the outlet of the syringe barrel 30.
  • the luer cover 50 is preferably a relatively pliable polymer material to provide a fluid seal and for compressive insertion into a longitudinally ribbed sleeve 52 positioned about the male luer connector 32.
  • the ribbed sleeve 52 slides into complementary channel 72 formed within the cartridge casing 26. This provides reliable positioning of the male luer connector 32 relative to the integrally molded engagement tabs 22. During inter-engagement of the dispenser 4 and the housing assembly 6, the closely toleranced positioning of the male luer connector 32 provides reliable engagement with the female luer connector 62 of the dispenser (see Figure 7).
  • the syringe barrel 30 provides a reservoir 30 for the medicament which is sealed at the upper end by the luer cover 50 and at its lower end by a plunger 24.
  • the plunger 24 is slides towards the male luer connector 32 of the syringe barrel to incrementally reduce the reservoir volume and expel a predetermined volume of medicament through the male luer connector 32.
  • the vacuum caused by the actuation of the spray pump 60 (or rather the automatic re-priming of the pump 60 immediately following actuation) draws the plunger along the syringe barrel as the medicament is dispensed.
  • the dispenser device 2 can be used in any orientation and will deliver a complete dose of medicament with each actuation. This has clear advantages in situations where the patients are themselves trapped in awkward positions.
  • the end cap 10 is carefully designed to avoid removal from the distal end of the cartridge casing 26, to prevent access to the syringe barrel 30 therein.
  • the end cap 10 slides up to the abutment flange 38 on the cartridge casing 26, where the outwardly biased snaplock formations 44 snap into the internal snaplock recess 78 at the base 46. This provides a tamper resistant feature in that the end cap cannot be subsequently removed for access to the syringe barrel 30 without obvious damage to the cartridge casing 26 and/or the end cap 10.
  • the dispenser 4 defines a flow path 66 extending from an inlet in the form of the female luer connector 62 to an outlet 12 at the upper end of the nozzle 14.
  • the length and diameter of the nozzle 14 is selected for nasal and/or oral delivery of the medicament.
  • other outlet configurations are also envisaged for dispensers to deliver the contents of the reservoir to other areas, such as ears, eyes or a close topical application.
  • the nozzle 14 is covered by a nozzle cap 56 to prevent ingress of contaminants via the outlet 12.
  • a flange At the base of the nozzle 14 on either side of the dispenser 4 is a flange defining a pair of finger grip surfaces 8.
  • the outer peripheral skirt 64 Depending from the periphery of the finger grip surfaces 8 is the outer peripheral skirt 64, in which the coupling features 16 are formed.
  • the nozzle 14 and the outer skirt 64 are preferably a single piece of polypropylene moulding which houses a spray insert 56, pump 60 and female luer connector 62. As the dispenser 4 and the housing assembly 6 inter-engage as described in detail above, the exposed end of the male luer connector 32 accurately aligns with the female luer connector 62.
  • spray insert 58, pump 60 and female luer connector 62 are well known components manufactured by a wide variety of companies.
  • suitable spray pumps are produced by Bona PHARMA of Changxin Road Guaunha Street, Langhua Area, Shen Zen 5181 10, Peoples Republic of China.
  • Other suitable pumps are produced by AptarGroup Inc., and Valois Corp of Connecticut U.S.
  • spray pumps of this type are relatively universal but typically they are fitted with a fitted with a simple‘dipstick’ tube from the pump to the reservoir of liquid, instead of the female luer connector used in the present invention.
  • This luer connector is added to the spray actuator such that it is resiliently biased away from the pump 60. Manually depressing the pump via finger grips 8 dispenses the contents through the spray insert 58 and subsequently the pump is biased back to a primed position, simultaneously re-priming the pump chamber with medicament from the syringe 30.
  • the plunger vacuum created by the pump 60 in the interior 36 of the syringe barrel 30, incrementally draws the plunger 24 towards the male luer connector 32.
  • a viewing window 28 formed in the cartridge casing 26 allows the user or medical staff to monitor the medicament levels and gage the total volume of medicament dispensed during treatment of a patient.
  • the plunger 24 is a colour that strongly contrasts with the medicament and remainder of the cartridge housing 26 for visual clarity.
  • the syringe barrel 30 may have markings that are viewed through the window 28 to indicate the remaining volume of medicament.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Mechanical Engineering (AREA)
  • Otolaryngology (AREA)
  • Biophysics (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

Un dispositif de distribution (2) pour distribuer une dose de fluide, tel qu'un médicament liquide ou un agent thérapeutique, qui a un distributeur (4) pour un actionnement par un utilisateur et un ensemble boîtier (6) avec un réservoir pour le liquide. L'utilisateur actionne le distributeur (4) pour distribuer une dose du liquide à travers un trajet d'écoulement s'étendant d'une entrée à une sortie (12) via une pompe. Lorsque la pompe est amorcée avec le liquide, l'actionnement du distributeur (4) distribue un dosage prédéterminé à travers la sortie (12). L'ensemble boîtier (6) a un raccord (16) pour venir en prise de façon détachable avec le distributeur (4) et former une connexion fluidique entre le réservoir de liquide et la sortie de distributeur (12). L'ensemble boîtier (6) comporte également un élément d'amorçage qui agit sur le réservoir en tant que raccord (16) entre en prise avec le distributeur (4) pour amorcer la pompe avec un liquide expulsé du réservoir.
PCT/AU2019/050613 2018-06-22 2019-06-14 Dispositif de dosage avec distributeur et cartouche Ceased WO2019241832A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2018902244A AU2018902244A0 (en) 2018-06-22 Dosage Device with Dispenser and Cartridge
AU2018902244 2018-06-22

Publications (1)

Publication Number Publication Date
WO2019241832A1 true WO2019241832A1 (fr) 2019-12-26

Family

ID=68982561

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/AU2019/050613 Ceased WO2019241832A1 (fr) 2018-06-22 2019-06-14 Dispositif de dosage avec distributeur et cartouche

Country Status (1)

Country Link
WO (1) WO2019241832A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3115210A1 (fr) * 2020-10-20 2022-04-22 Aptar France Sas Dispositif de distribution de produit fluide

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140371690A1 (en) * 2011-10-21 2014-12-18 Leo Pharma A/S Dispensing systems
WO2017008127A1 (fr) * 2015-07-16 2017-01-19 Gd Pharma Pty Ltd Dispositif de pulvérisation et cartouche de dosage

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140371690A1 (en) * 2011-10-21 2014-12-18 Leo Pharma A/S Dispensing systems
WO2017008127A1 (fr) * 2015-07-16 2017-01-19 Gd Pharma Pty Ltd Dispositif de pulvérisation et cartouche de dosage

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3115210A1 (fr) * 2020-10-20 2022-04-22 Aptar France Sas Dispositif de distribution de produit fluide
WO2022084631A1 (fr) 2020-10-20 2022-04-28 Aptar France Sas Dispositif de distribution de produit fluide

Similar Documents

Publication Publication Date Title
EP3723828B1 (fr) Dispositifs et procédés d'administration de doses de précision
US7335186B2 (en) Patient controlled drug delivery device
JP2728141B2 (ja) 使い捨て式無針注射装置
US10940274B2 (en) Nasal spray assembly
CN103025376B (zh) 喷雾器
CA2074219C (fr) Vaporisateur a seringue
US6605060B1 (en) Patient controlled drug delivery device
US5951526A (en) Syringe holder with integral dose divider
JP6880026B2 (ja) 医療用送達装置
CN1193283A (zh) 喷雾器
AU4769599A (en) A medical delivery device and a cartridge assembly for use in the same
JP2002503116A (ja) 再利用可能な投薬装置
MX2007007163A (es) Conjunto de jeringa que tiene un mecanismo inhabilitador.
CN102481405A (zh) 具有盖帽功能的药物输送系统和器械
JP2004537346A (ja) 液体を吹付ける装置
EP3200855B1 (fr) Ensemble de seringue
WO2019241832A1 (fr) Dispositif de dosage avec distributeur et cartouche
US20240374824A1 (en) Medical delivery device
WO2003004080A1 (fr) Seringue pour injecter un medicament
WO2017008127A1 (fr) Dispositif de pulvérisation et cartouche de dosage
CN220495269U (zh) 一种旋转按压伸缩结构以及注射装置
GB2478109A (en) A unit-dose container for administering liquid medicament to the buccal cavity
CN114146257B (zh) 给药装置和给药方法
EP4208232B1 (fr) Dispositif d'administration de médicament multidose rechargeable
WO2025149959A1 (fr) Système de distribution de médicament oral

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19822824

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19822824

Country of ref document: EP

Kind code of ref document: A1